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Abstract
Objective Impaired inhibition may perpetuate repetitive symptoms in obsessive-compulsive disorder
(OCD), however OCD-specific deficits have yet to be established. We investigated neural correlates of
inhibition in OCD vs. healthy and anxious controls. Methods ERPs and reaction times (RTs) were
compared between participants with OCD (n = 20), panic disorder (PD; n = 20) and healthy controls (HCs;
n = 20) during an adapted Go/NoGo task, which manipulated inhibitory difficulty. Results A classic P3
NoGo anteriorisation effect occurred across groups. Both clinical groups showed RT impairment, and
similar topographical anomalies of several (P2, N2 and P3) ERP components. Notably, both clinical
groups lacked the strong frontally maximal N2 component topography seen in the HCs, across stimuli.
Additionally, with increasing inhibitory difficulty, N2 latency increased in HCs but not in the clinical groups.
Conclusions Unexpectedly, ERP and behavioural anomalies during inhibition in OCD were not qualitatively
different to those in PD, but were generally more severe. Common general and inhibitory deficits may
underlie intrusive mental phenomena in both conditions. Significance This first ERP response inhibition
study in OCD to include anxious controls disconfirmed hypotheses regarding OCD-specific inhibitory
deficits, indicating the importance of comparing OCD to other conditions, to evaluate neurobiological
models.
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Highlights
•

We conducted the first event-related potential study of inhibitory processes in OCD to

include an anxious comparison group, in the search for OCD-specific deficits.
•

As in previous studies of inhibition, participants with OCD showed RT impairment,

and ERP anomalies during several (P2, N2, P3) information-processing stages, compared to
healthy controls.
•

Surprisingly, deficits and ERP anomalies did not differ qualitatively between OCD

and panic disorder, precluding OCD-specific interpretations and illustrating the importance of
including clinical comparison groups in future research, to advance neurobiological models
of OCD.
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Abstract
Objective: Impaired inhibition may perpetuate repetitive symptoms in obsessivecompulsive disorder (OCD), however OCD-specific deficits have yet to be established. We
investigated neural correlates of inhibition in OCD versus healthy and anxious controls.
Methods: ERPs and reaction times (RTs) were compared between participants with
OCD (n = 20), panic disorder (PD; n = 20) and healthy controls (HCs; n = 20) during an
adapted Go/ NoGo task, which manipulated inhibitory difficulty.
Results: A classic P3 NoGo anteriorisation effect occurred across groups. Both clinical
groups showed RT impairment, and similar topographical anomalies of several (P2, N2 and P3)
ERP components. Notably, both clinical groups lacked the strong frontally maximal N2
component topography seen in the HCs, across stimuli. Additionally, with increasing inhibitory
difficulty, N2 latency increased in HCs but not in the clinical groups.
Conclusions: Unexpectedly, ERP and behavioural anomalies during inhibition in OCD
were not qualitatively different to those in PD but were generally more severe. Common
general and inhibitory deficits may underlie intrusive mental phenomena in both conditions.
Significance: This first ERP response inhibition study in OCD to include anxious
controls disconfirmed hypotheses regarding OCD-specific inhibitory deficits, indicating the
importance of comparing OCD to other conditions, to evaluate neurobiological models.
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Introduction
Current approaches to OCD implicate additional neurobiological processes in its
aetiology compared to other anxiety disorders (Kuelz et al. 2004). Consequently, much
research has focused on identifying OCD-specific neuropsychological deficits which may
increase understanding of the pathophysiology underlying the disorder. While OCD has been
linked to a wide variety of neuropsychological deficits, particularly in executive processing and
inhibition, results are frequently inconsistent or are not replicated, and OCD-specific
impairments have yet to be clearly established (Greisberg and McKay 2003; Kuelz et al. 2004;
Simpson et al. 2006; Olley et al. 2007). The extent to which information-processing anomalies
in OCD overlap with those in other anxiety disorders is central to ongoing considerations of the
classification of OCD and its relationship to anxiety disorders versus other psychiatric
conditions (Stein et al. 2010; Bienvenu et al. 2012). While ERP studies have allowed the
nuanced study of inhibition in OCD, as with brain imaging studies (Rauch et al. 1997; van den
Heuvel et al. 2005; Radua et al. 2010), ERP studies comparing OCD with other disorders are
extremely rare (Oades et al. 1996; Schall et al. 1997; Miyata et al. 1998), limiting conclusions
regarding OCD-specific deficits.
Impaired sensorimotor inhibition, that is the ability to suppress task-irrelevant
information and to restrain prepotent behavioural responses when they are inappropriate
(Bjorklund and Harnishfeger 1995), has long been hypothesised to underlie repetitive
symptoms in OCD and has been widely investigated. The Go/NoGo task is commonly used to
investigate inhibitory processes, and requires withholding responses to infrequent “NoGo”
stimuli presented amongst frequent “Go” stimuli requiring a motor response. Some Go/NoGo
studies report impaired performance in OCD in the form of higher commission errors (Bannon
et al. 2002; Bannon et al. 2008) or slower reaction times (RTs; Aycicegi et al. 2003), however
most report no behavioural impairment in participants with OCD (Di Russo et al. 2000;
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Johannes et al. 2001; Herrmann et al. 2003; Maltby et al. 2005; Roth et al. 2007; Bohne et al.
2008). Studies using standard measures of inhibition have yet to build a consistent picture of
deficits in OCD, possibly due to the use of non-specific experimental tasks and test batteries
designed to indicate gross neuropsychological deficits which may not be sensitive to more
subtle anomalies seen in psychiatric disorders such as OCD (Sanz et al. 2001; Kuelz, Hohagen
et al. 2004). ERPs allow the study of subtle psychophysiological anomalies including those
which are not accompanied by behavioural deficits.
1.1 ERP studies of OCD
ERP studies of OCD have usually employed auditory oddball tasks, which measure
attention to standard (i.e. non-target) versus infrequent (i.e. target) stimuli. Differences between
OCD and healthy controls are usually reported, however specific findings differ considerably.
Differences in OCD relative to HCs include both larger (Towey et al. 1990; Towey et al. 1993)
and smaller N2 amplitudes (Morault et al. 1997), and both larger P3a amplitude (Gohle et al.
2008), and smaller P3 amplitude (Oades et al. 1996) have been reported. The inconsistent
direction of findings may be due to differing task and stimulus complexity and may indicate a
dysregulation (Morault et al. 1997) of N2 and P3 inhibitory processes rather than consistent
under- or over-activation of specific components. Additionally, increased N1 latency has been
reported in OCD, possibly indicating anomalies in stimulus discrimination (Morault et al.
1997). Reduced N2 and P3 latencies are reported in several studies (Towey et al. 1990; 1993;
Morault et al. 1997; Sanz et al. 2001; Kivircik et al. 2003), interpreted as a sign of cortical
over-arousal in OCD which may be linked to inhibitory deficits and intrusive symptoms
(Morault et al. 1997). Similar reduced
Go/NoGo tasks are considered better measures of inhibitory processes (Falkenstein et
al. 1999; Di Russo et al. 2000) because they establish pre-potent responding to Go stimuli, and
therefore greater difficulty inhibiting responses to NoGo stimuli. When healthy individuals
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withhold responses to NoGo stimuli, the N2 component is typically larger (Jodo and Kayama
1992; Eimer 1993; Falkenstein et al. 1999), and the P3 component is generally larger and more
frontally distributed (Roberts et al. 1994; Fallgatter and Strik 1999) than when they are
responding to Go stimuli, interpreted as neurophysiological correlates of inhibitory processes.
ERP latencies in Go/NoGo tasks are also related to inhibition. Longer P3 latency has been
reported in NoGo compared to Go conditions, interpreted as a sign of higher processing
demands in the NoGo condition (Fallgatter and Strik 1999; Salisbury et al. 2004). While studies
primarily focus on the N2/P3 complex in the Go/NoGo task, modulations in earlier waveform
components such as the P1, N1 or P2 may play major roles in determining inhibition success
(Roche et al. 2005).
Source analyses of ERP components during the Go/NoGo task indicate that the Go-P3
originates in the bilateral parietal lobes, the NoGo-P3 sources are mainly in the inferior anterior
cingulate cortex and lateral orbitofrontal area (Bokura et al. 2001), and the N2 component
originates in medial orbitofrontal and cingulate cortices (Bokura et al. 2001; 2002; Bekker et al.
2005). Because these regions are also implicated in the pathophysiology of OCD (Whiteside et
al. 2004), the Go/NoGo task seems particularly suitable for the study of OCD.
Two visual Go/NoGo studies (Malloy et al. 1989; Kim et al. 2007) report reduced
anteriorisation of the N2 during the NoGo condition in OCD compared to controls. In one study
this correlated negatively with Y-BOCS symptom severity, interpreted as a sign of inhibitory
deficits (Kim et al. 2007). Another study, however, reported increased NoGo N2 amplitudes in
OCD compared to healthy controls (Ruchsow et al. 2007). As with the oddball findings, the
inconsistencies may be due to differing task and stimulus complexity and may indicate a
dysregulation of N2 inhibitory processes which varies in direction (Morault et al. 1997). For the
P3, Hermann et al. (2003) found reduced frontal NoGo amplitude and reduced NoGo
anteriorisation in OCD, correlated negatively with YBOCs symptoms scores, again interpreted
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as indicating inhibitory deficits. Di Russo et al. (2000) found increased frontal P3 amplitude in
OCD patients to Go stimuli, relative to controls, with the OCD group having the same large P3
activation to both Go and NoGo stimuli, interpreted as a misallocation of cognitive resources in
OCD. With regard to latencies, one study found reduced N2 latencies to Go stimuli in OCD
relative to healthy controls (Herrmann et al. 2003).
Previous studies had small sample sizes of 8-13 OCD participants (Schall et al. 1997;
Di Russo et al. 2000; Herrmann et al. 2003; Ruchsow et al. 2007). Malloy et al. (1989) had a
larger sample of 18 OCD participants, however they analysed left side electrodes only. Only
one study we located (Schall et al. 1997) used a clinical comparison group (schizophrenia), and
there are apparently no studies in this area comparing OCD with an anxious control group,
limiting conclusions about OCD-specific deficits. Sensorimotor inhibitory deficits occur in
several psychiatric conditions, including attention-deficit hyperactivity disorder (Epstein et al.
2001), bipolar disorder (Murphy et al. 1999), depression (Paradiso et al. 1997), schizophrenia
(Braff 1993) and panic disorder (Ludewig et al. 2002; 2005), and further research is needed to
investigate the specificity of effects to OCD.
1.2 Additional methodological issues
One interpretive difficulty which arises in traditional Go/NoGo tasks is that ERP
differences may reflect the differential overlap of movement-related activity between Go and
NoGo stimuli, rather than purely variations in cognitive inhibitory activity (Kopp et al. 1996;
Falkenstein et al. 1999). We previously described a modified Go/NoGo task (Thomas et al.
2009) which addressed the issue of differential Go/NoGo movement overlap by establishing
four distinct categories of NoGo stimuli which had been differentially primed by preceding Go
stimuli and varied in inhibitory difficulty but not in response requirements. Different categories
of NoGo stimuli could therefore be compared as a function of inhibitory load, avoiding the
necessity for Go/NoGo comparisons. Following an fMRI study, (Durston et al. 2002), we
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predicted that inhibitory difficulty would be greater to NoGo stimuli preceded by larger
numbers of Go stimuli. As predicted, ERP effects varied systematically according to the
preceding context of stimuli. The traditional Go/NoGo analysis was also conducted, for
comparison with a large body of previous literature (Thomas et al. 2009).
In our previous study, increasing the numbers of preceding Go stimuli resulted in
incremental increases in N1, P2 and N2 latencies, interpreted as an indication of greater
inhibitory difficulty to NoGo stimuli as a function of preceding Go stimuli. ERP amplitudes
showed more complex higher-order effects with indications of inhibition which reversed
towards the end of longer stimulus trains, possibly due to anticipatory effects (Thomas et al.
2009). Thus we established a means of comparing ERPs to stimuli associated with differing
difficulty of inhibition, independent of motor confounds. Additionally, when we conducted the
standard Go/NoGo comparison, well established Go-NoGo effects were replicated, suggesting
that the modified task was comparable with previous Go/NoGo studies.
1.3 Panic disorder
Panic disorder is a common anxiety disorder which, like OCD, results in significant
impairment in functioning. The neurobiology of panic disorder is not yet fully understood,
however dominant models implicate both excessive activation, and impaired cortical inhibition,
of anxiety-related caudal limbic neural circuits (Coplan and Lydiard 1998). The prefrontal
cortex is also implicated in the core pathophysiology of panic disorder, with hypofrontality in
imaging studies being interpreted to indicate executive dysfunction and impaired prefrontal
cortical inhibition of hyperactivity of anxiety-related neural circuitry (Ohta et al. 2008).
Individuals with panic disorder therefore constitute a suitable comparison group in the search
for OCD-specific inhibitory deficits.
1.4 The current study
The current study used ERP and behavioural data to examine sensorimotor inhibition in
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OCD, to establish the nature of inhibitory anomalies, and the extent to which they are OCDspecific or shared with an anxiety disorder (PD). We used the experimental approach
established earlier with a healthy sample (Thomas et al. 2009). ERP measures, RT and
accuracy of responses were analysed to Go and NoGo stimuli in a standard Go/ NoGo
comparison. Additionally, we manipulated the difficulty of inhibition by varying the number of
Go stimuli which preceded NoGo stimuli. Forty clinical participants were recruited (20 with
diagnoses of OCD and 20 with PD) for comparison with the ERP and performance data for the
HCs previously reported (Thomas et al. 2009).
We predicted atypical activation and/or topography of N2 and P3 components, and of
the NoGo versus Go N2 and P3 components in OCD relative to HC. To support OCD-specific
inhibitory deficits, the OCD group should differ from both the healthy and anxious control
groups. Additionally, we predicted that comparison of NoGo stimuli differentially negatively
primed by preceding Go stimuli would provide further insight into inhibitory processes and that
the OCD group would show atypical ERP latencies with increasing difficulty of inhibition in
comparison to HC and anxious controls.
2. Method
2.1 Participants
Forty individuals participated in the current study: 20 with OCD and 20 with PD with or
without agoraphobia. Their data were compared with those of 20 HCs reported in our previous
study (Thomas et al. 2009). The data for the clinical groups were collected contemporaneously
with those for the healthy controls, in the same lab with identical testing procedures and
recording instrumentation. Because the clinical participants took longer to recruit, as is often
the case, we finished recruitment for the healthy controls earlier than the clinical groups.
Because of the novel nature of the methodology, we considered that it was important to first
publish a report which considered performance and neural correlates during this task in healthy
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participants, as a foundation for later interpreting the complex between-group analysis.
No individuals in the PD group had a personal or known family history of OCD or
obsessive-compulsive symptoms. Clinical participants were recruited through local clinics.
Diagnoses were confirmed using the Composite International Diagnostic Interview for DSMIV (World Health Organisation 1997). While some participants were prescribed occasional
benzodiazepines (Table 1), none had taken benzodiazepines in the preceding 48 hours. HCs
were free from past or present psychiatric disorders. Exclusion criteria across groups were head
injuries, neurological disorders, substance abuse and psychoses. The University of Wollongong
Ethics Committee approved the research protocol beforehand and participants gave written
informed consent.
2.2 Materials
Symptom types and severity were assessed using the Padua Inventory-Washington State
University Revision (PI-WSUR (Burns et al. 1996), the Yale-Brown Obsessive Compulsive
Scale (Goodman et al. 1989), the Brief Symptom Inventory (BSI; Derogatis and Melisaratos
1983) and Obsessional Beliefs Questionnaire (OBQ-44; Obsessive Compulsive Cognitions
Working Group 1997; 2001; 2005).
2.3 Stimuli
Stimuli were presented individually on a computer screen in white on a black
background. They comprised a baseline stimulus (!), a Go stimulus (), and a NoGo stimulus
(X). Two further stimuli were included for future comparisons of task-switching performance
and are not examined here (X-Go and dedicated NoGo), following at the end of stimulus trains.
Stimuli occurred in sequences or trains of 4-8 (See Figure 1.). Trains commenced with the
baseline stimulus, followed by between 1-4 Go stimuli (), followed by a NoGo stimulus (X).
The X-NoGo stimulus was followed on 50% of trials by a repetition of the X-stimulus (because
participants were required to respond to X-repetitions, this stimulus is termed X-Go) and on
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50% of trials by a square (dedicated NoGo stimulus). Thus a NoGo (N) stimulus occurred in
each train, but because N was preceded by one or more Go-stimuli, the overall ratio of Go:
NoGo stimuli presented to participants was 14:4 or 69%: 31%. Train types were equiprobable
and presented randomly. Stimulus duration was 200 ms. ISI varied randomly between 1-3 s
(mean 2 s) and inter train interval varied randomly between 4-6 s. Overall, 635 stimuli were
presented to participants in 70 trains.
2.4 Procedure
After completing interviews and questionnaires, participants were fitted with the
electrode cap. During the experiment participants were comfortably seated in a dimly lit soundattenuated room, 1m from the computer screen, with a button-press device fixed to a chair arm
next to their dominant hand.
2.5 Electrophysiological recording
The EEG was recorded from 19 scalp electrodes (F1, F2, F3, Fz, F4, F7, F8, T3, T4, T5,
T6, C3, Cz, C4, P3, Pz, P4, O1, O2) and referenced to linked ears according to the international
10 – 20 system (Jasper, 1958) using tin electrodes in an electrode cap. The participant was
grounded by a cap electrode located midway between Fpz and Fz. Vertical EOG was recorded
from electrodes placed 1 cm above and below the left eye, and electrodes placed beyond the
outer canthus of each eye recorded horizontal EOG. Electrode impedances were below 5kΩ.
2.6 Data analysis
One-way analyses of variance (ANOVAs) were used to compare groups on age and
psychometric variables. Significant differences between groups were followed by simple
effects comparisons to investigate which group differences were driving the effects. Fisher’s
exact test was used to compare group categorical variables.
Mean RTs for correct responses by stimulus type were calculated for each participant in
each task. Extreme scores (± 2 SDs from the participant's condition mean) were excluded
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(Ratcliff, 1993; Thomas et al. 2009). A one-way ANOVA was used to compare groups on RTs
to Go stimuli. Effects of the number of preceding Go stimuli upon commission errors to NoGo
stimuli were analysed using a 3 Group (HC, PD, OCD) x 4 Stimulus sequence position (GN,
GGN, GGGN, GGGGN) ANOVA. As described above, planned contrasts assessed linear and
quadratic effects for the Stimulus sequence position factor.
The ERP epoch was defined as 100 ms pre- to 800 ms post-stimulus. ERP data were
amplified with EEG and EOG gains of 20,000 and 5,000 respectively, digitized at a sampling
rate of 512 Hz with a bandpass down 3 dB at 0.01 and 35 Hz, and filtered offline with a low
pass zero phase shift filter at 30 Hz, 48dB/octave. Data were accepted after artifact rejection
(±100μV) and eye-movement correction (Semlitsch et al. 1986).
Five components were quantified, with amplitudes determined relative to the 100 ms
pre-stimulus baseline. Peaks were automatically detected in specified channels where they
generally showed maximal amplitude in the grand mean waveforms: O1 for P1 (50–140ms);
O2 for N1 (90–160 ms); Pz for P2 (150 - 210 ms); Fz for N2 (180 - 400 ms), and Pz for P3
(290 - 600 ms). Search windows were based on visual inspection of the grand mean
waveforms. Following automatic detection, individual peaks were visually inspected and
manually confirmed or corrected. Eleven sites were the focus of data analysis (F3, Fz, F4, C3,
Cz, C4, P3, Pz, P4, O1, O2). ERP latencies were recorded as the time during the search window
of maximal amplitude at the index channel, and the component amplitudes for all 11 electrodes
were taken at the same post-stimulus latency (Picton et al. 2000).
Within the lateral plane, two planned contrasts were computed: left versus right
hemispheres, and the midline region versus the mean of the left and right hemispheres. The
contrasts for the Sagittal factor were: (i) frontal vs. parietal electrodes and (ii) central vs. the
mean of the frontal and parietal electrodes. As the contrasts were planned and there were no
more of them than the degrees of freedom for an effect, no Bonferroni-type adjustment was
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necessary (Tabachnick et al. 2001). Greenhouse–Geisser corrections were applied where
appropriate. ERP data were normalised using the vector scaling procedure (McCarthy and
Wood 1985), and interactions involving topography are reported only if they remained
significant after normalisation.
To assess whether any Group effects or interactions may have been related to
medication status, for each clinical group separately, analyses were repeated as above with a
between group factor of Medication, with 2 levels (no medication, current medication).
Interactions and effects are only reported if no involved factor interacted with Medication.
3. Results
3.1 Group characteristics and psychometric variables
Tables 1 shows that there were no significant differences between groups for
demographic variables. Table 2 shows psychometric results, with the OCD group having higher
scores than the HC group on all measures of psychopathology. There were no significant
differences between the OCD and PD groups on measures of psychological symptoms, except
that the OCD group scored significantly higher on OCD symptoms (measured by the Padua
Inventory). The PD group scored higher than the HC group on all measures of
psychopathology, except in OCD symptoms.
3.2 Behavioural results
Table 3 shows behavioural data across groups. There were no interactions between
Medication and performance. There was an effect of Group on RT, F (2, 57) = 4.27, p = .02,
with both clinical groups having longer RTs than the HC group (OCD vs. HC: F (1, 38) = 5.48,
p = .025; PD vs. HC: F (1, 38) = 8.72, p = .005; PD vs. OCD: F (1, 38) = 1.5, p = .7). Accuracy
of responses to NoGo stimuli (NoGo-X) was high (99.9%) and did not differ by Group or as a
function of Go preceding NoGo stimuli.
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3.3 ERPs to Go versus NoGo stimuli
Table 4 shows all significant ERP effects and interactions involving Group, and
accompanying two-group comparisons. Grand mean waveforms to Go and NoGo stimuli are
shown in Figure 2. Mean ERPs to Go stimuli and NoGo (NoGo-X) stimuli were compared in a
Stimulus (Go, NoGo) x Sagittal (frontal, central, parietal) x Lateral (left, midline, right) x
Group (HC, PD, OCD) ANOVA. For N1 amplitude, an additional ANOVA was conducted at
occipital electrodes (O1, O2) with factors of Group (as above) x Stimulus type (as above) x
Lateral (left, right).
P1 amplitude was larger to NoGo than Go stimuli, F (1, 57) = 18.6, p < .001, and had a
greater central (versus fronto-parietal) effect to NoGo than Go stimuli, F (1, 57) = 11.27, p <
.01.
N1 amplitude was greater fronto-parietally (versus centrally) to NoGo than Go stimuli,
F (1, 57) = 7.78, p < .01. N1 amplitude was greater at lateral (vs. midline) sites, with this effect
being greater for NoGo compared to Go stimuli, F (1, 57) = 20.04, p < .01. N1 latency was
faster to Go than NoGo stimuli, F (1, 57) = 4.3, p < .05.
P2 amplitude was larger, F (1, 57) = 7.18, p < .01, and showed a stronger parietal >
frontal effect, F (1, 57) = 6.92, p < .05, to NoGo than Go stimuli. P2 latency was faster to Go
than NoGo stimuli, F (1, 57) = 9.39, p < .01.
For N2, the Group by Sagittal interaction was significant, F (2, 57) = 3.28, p < .05, with
both clinical groups having the same atypical topography of N2 amplitude across Go and NoGo
stimuli, and an absence of the frontal > parietal topography seen in the HCs. N2 amplitude was
greater centrally (versus fronto-parietally) to NoGo than Go stimuli, F (1, 57) = 6.81, p < .05.
N2 latency was faster to Go than NoGo stimuli, F (1, 57) = 8.54, p < .01.
P3 amplitude was larger to NoGo than Go stimuli, F (1, 57) = 4.04, p < .05. P3
amplitude showed a stronger frontal (vs. parietal) effect to NoGo than Go stimuli (i.e. a NoGo
anteriorisation effect), F (1, 57) = 5.35, p < .05 and a greater central (versus fronto-parietal)
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effect to NoGo than Go stimuli, F (1, 57) = 28.57, p < .001. P3 latency was faster to Go than
NoGo stimuli, F (1, 57) = 5.94, p < .05.
3.4 ERPs to NoGo stimuli as a function of preceding sequence
Mean ERPs to NoGo stimuli as a function of the number of preceding Go stimuli are
shown in Figure 4. ERPs to NoGo stimuli were analysed using an ANOVA with Group x
Stimulus sequence (GN, GGN, GGGN, GGGGN) x Sagittal x Lateral factors as above. For N1
amplitude, an additional ANOVA was conducted at occipital electrodes (as before). Because
the focus of the current study is between-group differences, only interactions involving Group
are reported here. A detailed consideration of sequence effects in the current experimental
approach appears elsewhere (Thomas et al. 2009). Mean ERP amplitudes to NoGo stimuli for
significant Group effects and interactions are plotted in Figure 5, and latencies in Figure 6.
P1 amplitude showed a Group by Laterality (linear) interaction, F (2, 57) = 4.4, p < .05,
driven by increased right versus left hemisphere amplitude for P1 to NoGo stimuli in the PD
versus OCD and HC groups.
N1 amplitude showed a Group by Laterality (linear) interaction, F (2, 57) = 3.3, p < .05,
driven by reduced N1 amplitude in the left versus right hemisphere to NoGo stimuli in PD
relative to HCs (Table 4). Table 4 shows a main effect of Group for N1 latency, F (2, 57) =
6.84, p < .01, driven by significantly longer N1 latencies to NoGo stimuli in the OCD than HC
group (Figure 6).
For P2, a main effect of Group, F (2, 57) = 3.97, p < .05, and simple effects showed that
the OCD group had significantly smaller P2 amplitude to NoGo stimuli than HCs. A Group by
Sagittal interaction, F (2, 57) = 12.08, p < .01, and simple effects showed that the OCD group
had significantly reduced parietal versus frontal P2 amplitude to NoGo stimuli compared to HC
and PD groups. This effect was also present in the PD group relative to HCs.
For N2, a Group by Sagittal (frontal vs. parietal) interaction for N2 amplitude to NoGo
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stimuli, F (2, 57) = 5.21, p < .01, and simple effects showed a stronger frontal > parietal effect
for N2 amplitude to NoGo stimuli in HCs than OCD and PD groups. N2 latency showed a main
effect of Group, F (2, 57) = 3.51, p < .05, with the PD group having shorter N2 latencies than
the OCD and HC groups. The Stimulus (linear) by Group interaction, F (2, 57) = 4.41, p < .05,
was significant, driven by both clinical groups failing to show the increase in N2 latency as a
function of Go preceding NoGo stimuli evidenced by the HCs.
P3 amplitude showed a significant Group by Sagittal (frontal vs. parietal) interaction, F
(2, 57) = 5.51, p < .01. Simple effects analyses indicated atypical topography of P3 amplitude
in both clinical groups, with reduced parietal versus frontal P3 compared to HCs.
3.5 Relationships between experimental effects and symptoms
We conducted selective Pearson correlations to examine relationships between the
above significant effects and symptom severity as measured by the Y-BOCS, the BSI (Anxiety,
Obsessive-compulsive and Depression subscales, Global Severity Index and Positive Symptom
Distress Index), the PI-WSUR, and the OBQ-44.
RT to Go stimuli was positively correlated with Y-BOCS Obsessions, r (20) = .50, p <
.05, and Compulsions, r (20) = .49, p < .05. For ERPs, only correlations significant at the 0.01
level are reported. N2: Right parietal amplitude to NoGo stimuli was negatively correlated to
BSI Anxiety, r (60) = -.34. Left parietal amplitude to Go stimuli negatively correlated to OBQ
total, Responsibility/Threat, Importance/Control of Thoughts, Thoughts of harm, BSI OC,
Anxiety, Global Severity Index, Positive Symptom Total and Positive Symptom Distress Index,
r (60) between -.34 and -.43. Midline parietal amplitude to Go stimuli negatively correlated to
OBQ total, r (60) = -.34, and Importance/ Control of Thoughts, r (60) = -.41. Right parietal
amplitude to Go stimuli negatively correlated to OBQ Importance/ Control of Thoughts, r (60)
= -.41, BSI Anxiety, r (60) = -.37 and BSI Positive Symptom Total, r (60) = -.34. For P3,
latency to Go stimuli correlated positively with BSI Anxiety, r (60) = -.35.
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4. Discussion
Current models of OCD implicate additional neurobiological processes compared to
other anxiety-related disorders (e.g., Kuelz et al. 2004). While numerous ERP studies have
attempted to identify neuropsychological factors which may increase understanding of the
pathophysiology of OCD, very few have included clinical comparison groups, thus limiting
conclusions about OCD-specific deficits. The current study addressed these limitations by
including an anxious comparison group with PD, having similar levels of symptom severity but
without any personal or family history of OCD. Although there have been several previous
studies of neural activity accompanying response inhibition in OCD, to our knowledge this was
the first to include an anxious comparison group. Additionally, we employed a specially
modified Go/NoGo task (Thomas et al. 2009) which included an additional examination of
inhibitory processes which avoided some of the interpretive limitations when comparing Go
with NoGo stimuli. This task allowed the comparison of different groups of NoGo stimuli with
each other which were differentially primed by preceding Go stimuli, and therefore differed in
inhibitory difficulty while not having the response requirement differences inherent in Go/
NoGo comparisons.
4.1 Go/Nogo Comparison
When we followed the well-established method of comparing ERPs to Go versus NoGo
stimuli, P3 amplitude was larger and showed a stronger frontal (vs. parietal) effect to NoGo
than Go stimuli (i.e. a classic NoGo anteriorisation effect), across groups. This is consistent
with previous OCD studies (e.g. Kim et al. 2007), and indicates that the task was comparable to
existing Go/NoGo studies, with NoGo stimuli being associated with ERP responses typically
interpreted as indexing brain inhibitory mechanisms (Roberts et al. 1994; Fallgatter and Strik
1999) in both the clinical and healthy groups.
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Both clinical groups, however, showed remarkably similar atypical topography of N2
across stimuli, with more posteriorly distributed N2 amplitudes and an absence of the strong
frontally maximal topography seen in the HC group. Additionally, greater negativity of N2 in
parietal regions was related to several measures of psychopathology including obsessional
beliefs, obsessive-compulsive symptoms, anxiety, and overall severity of psychological
symptoms and distress. This was localised to the right hemisphere for NoGo stimuli but
occurred across left, midline and right parietal sites to Go stimuli.
Previously, Kim et al. (2007) also reported a more posteriorly distributed NoGo N2 in
OCD compared to controls, correlated with symptom severity, which they interpreted as
indicating inhibitory deficits in OCD, possibly induced by dysfunctions of the inferior
prefrontal cortex and contributing to the pathophysiology of OCD. Also, a more posteriorly
distributed NoGo N2 has been reported in children relative to adults, interpreted to indicate the
effortful recruitment of more primitive brain regions, such as the striatum, for inhibitory control
before the prefrontal brain regions are fully mature (Ciesielski et al. 2004; Jonkman et al.
2007). In the current study this posteriorly distributed N2 negativity occurred across Go and
NoGo stimuli, suggesting a general processing anomaly such as a misallocation of cognitive
resources noted in previous OCD studies (Di Russo et al. 2000), rather than purely an
inhibitory deficit. Posterior shifts in N2 topography have been linked to the effects of
noradrenaline release on cortical processing (Warren et al. 2011). It is possible that the atypical
N2 topography reflects recruitment of additional cortical areas in task performance in the
clinical groups, linked to catecholamine release, however further research is needed.
Occurrence of the same pattern of topographical abnormalities in participants with panic
disorder and no history of OCD militates against an OCD-specific interpretation.
Consistent with previous research, N1, P2, N2 and P3 latencies were prolonged to
NoGo compared to Go stimuli across groups, likely indicating the higher processing demands
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involved in inhibiting, compared to executing, anticipated actions (Fallgatter and Strik 1999).
Both clinical groups had general RT slowing to Go stimuli. RT impairment in participants with
OCD was positively related to (Y-BOCS) symptom severity. Longer RTs to Go stimuli have
been reported previously in OCD relative to HCs (Aycicegi et al. 2003), however many studies
find no impairment (Di Russo et al. 2000; Johannes et al. 2001; Herrmann et al. 2003; Roth et
al. 2007; Bohne et al. 2008). Reviews of neuropsychological performance in OCD (Kuelz et al.
2004; Olley, Malhi et al. 2007) conclude that task performance is often at a similar overall level
to controls, but is accompanied by longer RTs in about half the studies, indicating that accuracy
may be accomplished at a cost to speed. Medication status did not interact with RTs in the
current study, and it is therefore concluded that both anxious groups showed general RT
slowness associated with clinical status. This interpretation was supported by the correlation
between P3 latency to Go stimuli and BSI Anxiety severity, suggesting that clinical anxiety
was associated both with slower cognitive as well as motor responses to Go stimuli. In
summary of the Go versus NoGo results, this is to our knowledge the first ERP Go/NoGo study
which included an anxious comparison group, and no OCD-specific inhibitory or general
deficits were detected.
4.2 Inhibitory load manipulation
The current study also manipulated the difficulty of withholding responses to NoGo
stimuli by varying the number of preceding Go stimuli. By comparing NoGo stimuli of varying
inhibitory difficulty we could examine the neural correlates of inhibition while avoiding the
interpretive difficulties inherent in Go/ NoGo comparisons, such as motor movements
overlapping ERPs to a greater extent for Go than NoGo stimuli (Kopp et al. 1996; Falkenstein
et al. 1999). We initially trialed this modified Go/NoGo task in healthy participants and found
that increasing the number of Go stimuli before NoGo stimuli led to ERP indications of greater
inhibitory difficulty including incremental increases in N1, P2 and N2 latencies (Thomas et al.
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2009). Because the aim of the current study was to identify OCD-specific inhibitory deficits,
we focus here on between-group differences. Further information about sequence effects in this
task as a result of experimental manipulations is considered in more detail elsewhere (Thomas
et al. 2009).
In the current study, both anxious groups failed to show the increase in N2 latency as a
function of the number of Go preceding NoGo stimuli evidenced by the HCs. Towey et al.
(1993) reported that increasing task difficulty resulted in longer N2 and P3 latencies in HCs,
but not in OCD patients in an auditory oddball task. A defining feature of inhibitory brain
processes is a decrement (in speed or accuracy) resulting from previous stimulation (Posner and
Snyder 1975; Buckner et al. 1998; Klein 2000), and longer ERP latencies to NoGo than Go
stimuli are attributed to higher processing demands when withholding than executing
anticipated actions (Fallgatter and Strik 1999; Herrmann et al. 2003; Salisbury et al. 2004). The
N2 ERP component is considered a key neurophysiological aspect of response inhibition
processes (Kaiser et al. 2006). Failure of both anxious groups to show the increase in N2
latency evidenced by the HCs with increasing inhibitory load may indicate anomalous brain
inhibitory mechanisms in both clinical groups.
The OCD group had longer N1 latencies to NoGo stimuli than the HCs. N1 latency
increases with increased attention to stimuli, and with effort at processing (Callaway and
Halliday 1982). One previous ERP Go/NoGo study reported longer N1 latency to Go stimuli in
OCD (Di Russo et al. 2000) while others found no significant differences between control and
OCD ERP latencies (Malloy et al. 1989; Schall et al. 1997; Herrmann et al. 2003; Ruchsow et
al. 2007). Longer N1 latencies in OCD were also reported in an oddball task (Morault et al.
1997). The current findings may indicate slower or more effortful early discriminative
processing (Oades et al. 1996) in OCD.
Participants with OCD had smaller P2 amplitude, particularly parietally, to NoGo
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stimuli relative to HCs. The P2 is interpreted as representing stimulus discrimination and
classification (Dowman 2004) and inhibitory processes (Coburn et al. 2005) and is affected by
vigilance and arousal (Oades et al. 1996). Reduced P2 latency has been linked to weakness of
inhibition (Muller and Roberts 2005). Smaller P2 amplitudes have previously been reported in
participants with OCD, relative to HCs and those with schizophrenia, during an auditory
oddball task (Oades, Zerbin et al. 1996). P2 amplitude increases with faster, more accurate
performance in Go/NoGo tasks (Johnstone et al. 2001), suggesting that it is related to stimulus
evaluation processes underlying optimal performance. Several studies demonstrate a
dependence of P2 amplitude on serotonin activity (Norra et al. ; Hegerl and Juckel 1993;
Hegerl et al. 2001; Juckel et al. 2003; Senkowski et al. 2003; Juckel et al. 2008). Serotonin
dysregulation is implicated in the pathogenesis of OCD (Hesse et al. 2005; Baca-Garcia et al.
2007; Lin 2007; Goddard et al. 2008; Perani et al. 2008; Matsumoto et al. 2010) and anxiety
disorders generally, including panic disorder (Coplan and Lydiard 1998; Bandelow et al. 2008).
It is therefore notable that the PD group showed intermediate P2 amplitude between the HCs
and OCD group, and shared P2 topographical anomalies with OCD relative to the HCs. In a
previous study, participants with PD had reduced P2 amplitude to non-targets, compared to
healthy controls (Wang et al. 2003). Taken in conjunction with previous research, the current
P2 results may indicate shared anomalies in arousal, vigilance or inhibition in OCD and panic
disorders.
In the current study, both clinical groups also shared atypical topography of the NoGo
P3, with lower parietal relative to frontal amplitude compared to HCs. Lower parietal P3,
which improves after treatment with SSRIs, has been previously reported in OCD, interpreted
as a sign of general cognitive and inhibitory dysfunction (Sanz et al. 2001). Additionally,
higher frontal cortical activation in OCD has been noted in several studies (reviewed in Saxena
and Rauch 2000). These patterns are typically interpreted within a model of OCD-specific
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posterior cortical under-activation and anterior cortical over-activation of a primary or
compensatory nature (Ciesielski et al. 2005; Menzies et al. 2008). The current results, however,
indicate that abnormalities in parietal activation are not OCD-specific but common to PD.
Additionally, the P3 results must be viewed in the context that in the current study both clinical
groups showed increased parietal negativity across several (P2, N2 and P3) informationprocessing stages. Parietal brain regions are increasingly implicated in both OCD (Ciesielski et
al. 2005; Menzies et al. 2008) and PD (Alemayehu et al. 1995; Heller et al. 1997; Bisaga et al.
1998), and the current results support the consideration of their role in information-processing
in these disorders.
4.3 Summary and integration
Overall, participants with OCD showed several significant differences from HCs in
performance and ERP measures in the Go/NoGo task. Similar anomalies have been reported in
previous ERP studies of OCD, including RT impairment (see Kuelz et al. 2004; Olley et al.
2007), more posteriorly distributed N2 amplitude (Kim et al. 2007), a failure to show
increasing N2 latency with increasing task difficulty (Towey et al. 1993), longer N1 latencies to
NoGo stimuli (Di Russo et al. 2000) and smaller P2 amplitude (Oades, Zerbin et al. 1996).
Surprisingly, however, with the inclusion of an anxious comparison group in the current
study, we found that participants with PD showed remarkably similar performance and ERP
anomalies to the OCD group. For most effects, the OCD group differed significantly only from
the HCs and the PD group showed an intermediate effect. There were only two findings where
the OCD group differed significantly from both the HC and PD groups. The first was greater
scores on measures of OCD symptoms (e.g. Padua) in the OCD than other groups, as would be
predicted. The second was a reduced parietal: frontal topography of P2 to NoGo stimuli,
however the PD group showed this same atypical topography and also differed significantly
from the HCs for this effect, suggesting that the same underlying processes were present in
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both clinical conditions, but were more pronounced in OCD than in PD.
The current pattern of results leads to the suggestion that general and inhibitory
anomalies in the current study are not OCD-specific but may represent common abnormalities
among these disorders. Additionally, it highlights the need for caution in interpreting the results
of studies of OCD without anxious control groups. The only previous ERP study of which we
are aware to include an anxious control group found N2 abnormalities in OCD versus HCs in
an oddball task for target and non-target stimuli, with N2 negativity for a social phobic
comparison group falling halfway between, supporting a similar interpretation.
These findings have implications for understanding the extent to which OCD is
associated with unique deficits and psychophysiological activity relative to panic disorder. The
extent to which pathological processes in OCD overlap with anxiety disorders such as PD has
important nosological and clinical implications. Very few previous studies of brain activity in
OCD included anxious control groups, including the majority of neuroimaging studies upon
which neurobiological models of OCD (e.g. Saxena and Rauch 2000; Whiteside, Port et al.
2004) have been developed. Inclusion of a PD group showing equivalent levels of symptom
severity and medication status led to results which are more consistent with conceptualisations
of a considerable overlap in the neural substrates of OCD with PD rather than with models
emphasising a unique neural signature in OCD (Mataix-Cols and van den Heuvel 2006). The
overlapping ERP and behavioural results during response inhibition in the current study may be
related to other shared phenomena between the two disorders. Both OCD and PD share
symptoms of anxiety and behavioural avoidance, although with different foci and
manifestations (Miyata et al. 1998; Bartz and Hollander 2006). For both conditions, first line
treatments include SSRIs and tricyclic antidepressants (TCAs), often with higher doses in
OCD, and cognitive behavioural therapy (CBT). Both disorders are characterised by failures to
inhibit irrelevant and repetitive stimuli (Amir et al. 2001; Wise et al. 2009).
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These results support recent observations that the tendency to study OCD in isolation
from other disorders may have been an important barrier to progress in determining OCDspecific versus general (disorder nonspecific) etiologic factors (Taylor 2012). If an inhibitory
deficit is not specific to OCD, its importance in aetiological theories declines because it cannot
be a necessary and sufficient cause of the disorder (see Nigg 2000).
4.4 Caveats and future directions
Some clinical participants were prescribed medication at the time of testing. Previous
ERP studies of OCD include medicated participants (Malloy et al. 1989; Sanz, Molina et al.
2001; Herrmann et al. 2003; Ruchsow et al. 2007; Bohne et al. 2008; Hashimoto et al. 2008),
which may be due to difficulties in recruiting research participants with OCD (Muller and
Roberts 2005) as well as practical and ethical difficulties in finding off-medication patients
(Clark et al. 2009). We addressed confounds of comparing a medicated clinical group with
drug- naïve healthy controls by the inclusion of a clinical comparison group, taking similar
levels and types of medications and differing significantly only on measures of OCD. Data
were also reanalysed with medication as a between-subjects factor and found no interaction
between medication status and any performance variables or ERP latencies. There were a small
number of interactions between ERP amplitude topography or stimulus type and medication,
and these results were excluded from reporting, reducing the likelihood of medication effects
accounting for the current results. Nonetheless it is possible that medications influenced the
results.
As in most OCD ERP research the current study examined inhibitory processes to
neutral stimuli only. Because individuals with OCD do not complain of global inhibitory
deficits, but struggle to inhibit personally repugnant thoughts (Moritz et al. 2009), there is a
need to investigate inhibition in relation to affective stimuli. Indeed there is some evidence of
disorder-specific neural activity to affective stimuli between individuals with OCD and those
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with panic disorder (van den Heuvel, Veltman et al. 2005; Thomas et al. 2013).
4.5 Conclusions
In the current study, ERP and behavioural anomalies in OCD during a response
inhibition task were not qualitatively different to those in PD but were generally more severe.
Previous research may have overestimated the specificity of deficits to OCD, due to a lack of
clinical comparison groups. Additionally, the extent of inhibitory deficits in PD may have been
inadequately explored. The current study highlights the need for further research using anxious
comparison groups, to improve neurobiological models of OCD.

26
References
Alemayehu S, Bergey GK, Barry E, Krumholz A, Wolf A, Fleming CP, et al. Panic attacks as
ictal manifestations of parietal lobe seizures. Epilepsia. 1995;36:824-30.
Amir N, Freshman M, Ramsey B, Neary E, Brigidi B. Thought-action fusion in individuals
with OCD symptoms. Behav Res Ther. 2001;39:765-76.
Aycicegi A, Dinn WM, Harris CL, Erkmen H. Neuropsychological function in obsessivecompulsive disorder: effects of comorbid conditions on task performance. Eur
Psychiatry. 2003;18:241-8.
Baca-Garcia E, Vaquero-Lorenzo C, Diaz-Hernandez M, Rodriguez-Salgado B, DolengevichSegal H, Arrojo-Romero M, et al. Association between obsessive-compulsive disorder
and a variable number of tandem repeats polymorphism in intron 2 of the serotonin
transporter gene. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:416-20.
Bandelow B, Zohar J, Hollander E, Kasper S. World Federation of Societies of Biological
Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety,
Obsessive-Compulsive and Post-Traumatic Stress Disorders–First Revision. World J
Biol Psychiatry. 2008;9:248-312.
Bannon S, Gonsalvez CJ, Croft RJ. Processing impairments in OCD: It is more than inhibition!
Behav Res Ther. 2008;46:689-700.
Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM. Response inhibition deficits in obsessivecompulsive disorder. Psychiatry Res. 2002 2002/6/1;110:165-74.
Bartz JA, Hollander E. Is obsessive-compulsive disorder an anxiety disorder? Prog
Neuropsychopharmacol Biol Psychiatry. 2006;30:338-52.
Bekker EM, Kenemans JL, Verbaten MN. Source analysis of the N2 in a cued Go/NoGo task.
Cogn Brain Res. 2005;22:221-31.
Bienvenu OJ, Rasmussen SA, Fyer AJ, Pinto A, Rauch SL, Pauls DL, et al. Is obsessive–
compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A
family study perspective. Psychol Med. 2012;42:1-13.
Bisaga A, Katz JL, Antonini A, Wright E, et al. Cerebral glucose metabolism in women with
panic disorder. American J Psychiatry. 1998;155:1178-83.
Bjorklund DF, Harnishfeger K. The evolution of inhibition mechanisms and their role in human
cognition and behaviour. In: Dempster CJB, editor. Interference and inhibition in
cognition. London: Academic Press, Inc.; 1995.
Bohne A, Savage CR, Deckersbach T, Keuthen NJ, Wilhelm S. Motor inhibition in
trichotillomania and obsessive-compulsive disorder. J Psychiatr Res. 2008;42:141-50.
Bokura H, Yamaguchi S, Kobayashi S. Electrophysiological correlates for response inhibition
in a Go/NoGo task. Clin Neurophysiol. 2001;112:2224-32.
Bokura H, Yamaguchi S, Matsubara M, Kobayashi S, editors. Frontal lobe contribution to
response inhibition process—an ERP study and aging effect.2002: Elsevier.
Braff DL. Information Processing and Attention Dysfunctions in Schizophrenia. Schizophr
Bull. 1993;19:233-59.
Buckner RL, Goodman J, Burock M, Rotte M, Koutstaal W, Schacter D, et al. FunctionalAnatomic Correlates of Object Priming in Humans Revealed by Rapid Presentation
Event-Related fMRI. Neuron. 1998;20:285-96.
Burns GL, Keortge SG, Formea GM, Sternberger LG. Revision of the Padua Inventory of
obsessive compulsive disorder symptoms: distinctions between worry, obsessions, and
compulsions. Behav Res Ther. 1996;34:163-73.
Callaway E, Halliday R. The effect of attentional effort on visual evoked potential N1 latency.
Psychiatr Res. 1982;7:299-308.
Ciesielski KT, Hämäläinen MS, Lesnik PG, Geller DA, Ahlfors SP. Increased MEG activation

27
in OCD reflects a compensatory mechanism specific to the phase of a visual working
memory task. NeuroImage. 2005;24:1180-91.
Ciesielski KT, Harris RJ, Cofer LF. Posterior brain ERP patterns related to the go/no‐go task in
children. Psychophysiology. 2004;41:882-92.
Clark CR, Galletly CA, Ash DJ, Moores KA, Penrose RA, McFarlane AC. Evidence-based
medicine evaluation of electrophysiological studies of the anxiety disorders. Clin EEG
neurosci. 2009;40:84.
Coburn KL, Amoss RT, Arruda JE, Kizer LD, Marshall YS. Effects of flash mode and intensity
on P2 component latency and amplitude. Int J Psychophysiol. 2005;55:323-31.
Coplan JD, Lydiard RB. Brain circuits in panic disorder. Biol Psychiatry. 1998;44:1264-76.
Derogatis LR, Melisaratos N. The Brief Symptom Inventory- An introductory report. Psychol
Med. 1983;13:595-605.
Di Russo F, Zaccara G, Ragazzoni A, Pallanti S. Abnormal visual event-related potentials in
obsessive-compulsive disorder without panic disorder or depression comorbidity. J.
Psychiatr Res. 2000;34:75-82.
Dowman R. The Pain-Evoked P2 Is Not a P3a Event-Related Potential. Brain Topogr.
2004;17:3.
Durston S, Thomas KM, Worden MS, Yang Y, Casey BJ. The Effect of Preceding Context on
Inhibition: An Event-Related fMRI Study. NeuroImage. 2002;16:449-53.
Eimer M. Effects of attention and stimulus probability on ERPs in a Go/Nogo task. Biol
Psychology. 1993;35:123-38.
Epstein JN, Johnson DE, Varia IM, Conners CK. Neuropsychological assessment of response
inhibition in adults with ADHD. J Clin Exp Neuropsychol. 2001;23:362-71.
Falkenstein M, Hoormann J, Hohnsbein J. ERP components in Go/Nogo tasks and their relation
to inhibition. Acta Psychol. (Amst.). 1999;101:267-91.
Fallgatter AJ, Strik WK. The NoGo-anteriorization as a neurophysiological standard-index for
cognitive response control. Int J Psychophysiol. 1999;32:233-8.
Goddard AW, Shekhar A, Whiteman AF, McDougle CJ. Serotoninergic mechanisms in the
treatment of obsessive-compulsive disorder. Drug Discov Today. 2008;13:325-32.
Gohle D, Juckel G, Mavrogiorgou P, Pogarell O, Mulert C, Rujescu D, et al.
Electrophysiological evidence for cortical abnormalities in obsessive-compulsive
disorder - A replication study using auditory event-related P300 subcomponents. J.
Psychiatr Res. 2008;42:297-303.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The
Yale-Brown obsessive compulsive scale. Arch Gen Psychiatry. 1989;46:1006-11.
Greisberg S, McKay D. Neuropsychology of obsessive-compulsive disorder: a review and
treatment implications. Clin Psychol Rev 2003;23:95-117.
Hashimoto T, Shimizu E, Koike K, Orita Y, Suzuki T, Kanahara N, et al. Deficits in auditory
P50 inhibition in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol
Psychiatry. 2008;32:288-96.
Hegerl U, Gallinat J, Juckel G. Event-related potentials: Do they reflect central serotonergic
neurotransmission and do they predict clinical response to serotonin agonists? J Affect
Disord. 2001;62:93-100.
Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of
central serotonergic neurotransmission: A new hypothesis. Biol Psychiatry.
1993;33:173-87.
Heller W, Nitschke JB, Etienne MA, Miller GA. Patterns of regional brain activity differentiate
types of anxiety. J Abnorm Psychol. 1997;106:376-85.
Herrmann MJ, Jacob C, Unterecker S, Fallgatter AJ. Reduced response-inhibition in obsessivecompulsive disorder measured with topographic evoked potential mapping. Psychiatr

28
Res. 2003;120:265-71.
Hesse S, Muller U, Lincke T, Barthel H, Villmann T, Angermeyer MC, et al. Serotonin and
dopamine transporter imaging in patients with obsessive-compulsive disorder.
Psychiatry Research: Neuroimaging. 2005;140:63-72.
Jodo E, Kayama Y. Relation of a negative ERP component to response inhibition in a Go/Nogo task. Electroencephalogr and Clin Neurophysiol. 1992;82:477-82.
Johannes S, Wieringa BM, Nager W, Rada D, Dengler R, Emrich HM, et al. Discrepant target
detection and action monitoring in obsessive-compulsive disorder. Psychiatr Res:
Neuroimaging. 2001;108:101-10.
Johnstone SJ, Barry RJ, Anderson JW. Topographic distribution and developmental timecourse
of auditory event-related potentials in two subtypes of attention-deficit hyperactivity
disorder. Int J Psychophysiol. 2001;42:73-94.
Jonkman LM, Sniedt FLF, Kemner C. Source localization of the Nogo-N2: A developmental
study. Clin Neurophysiol. 2007;118:1069-77.
Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Möller H-J, et al. Serotonergic dysfunction
in schizophrenia assessed by the loudness dependence measure of primary auditory
cortex evoked activity. Schizophr Rese. 2003;64:115-24.
Juckel G, Gudlowski Y, Müller D, Özgürdal S, Brüne M, Gallinat J, et al. Loudness
dependence of the auditory evoked N1/P2 component as an indicator of serotonergic
dysfunction in patients with schizophrenia - A replication study. Psychiatr Res.
2008;158:79-82.
Kaiser S, Weiss O, Hill H, Markela-Lerenc J, Kiefer M, Weisbrod M. N2 event-related
potential correlates of response inhibition in an auditory Go/Nogo task. Int J
Psychophysiol. 2006:279-82.
Kim M-S, Kim YY, Yoo SY, Kwon JS. Electrophysiological correlates of behavioral response
inhibition in patients with obsessive–compulsive disorder. Depress Anxiety.
2007;24:22-31.
Kivircik BB, Yener GG, Alptekin K, Aydin H. Event-related potentials and neuropsychological
tests in obsessive-compulsive disorder. Prog. Neuropsychopharmacol Biol Psychiatry.
2003 2003/6;27:601-6.
Klein RM. Inhibition of return. Trends Cogn Sci. 2000;4:138-47.
Kopp B, Mattler U, Goertz R, Rist F. N2, P3 and the lateralized readiness potential in a nogo
task involving selective response priming. Electroen Clin Neuro. 1996;99:19-27.
Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessivecompulsive disorder: a critical review. Biol Psychol. 2004;65:185-236.
Lin P-Y. Meta-analysis of the association of serotonin transporter gene polymorphism with
obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry.
2007;31:683-9.
Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K.
Information-processing deficits and cognitive dysfunction in panic disorder. J
Psychiatry Neurosci. 2005;30:37.
Ludewig S, Ludewig K, Geyer M, Hell D, Vollenweider F. Prepulse inhibition deficits in
patients with panic disorder. Depress Anxiety. 2002;15:55-60.
Malloy P, Rasmussen S, Braden W, Haier RJ. Topographic evoked potential mapping in
obsessive-compulsive disorder: Evidence of frontal lobe dysfunction. Psychiatr Res.
1989;28:63-71.
Maltby N, Tolin DF, Worhunsky P, O'Keefe TM, Kiehl KA. Dysfunctional action monitoring
hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an eventrelated fMRI study. NeuroImage. 2005;24:495-503.
Mataix-Cols D, van den Heuvel OA. Common and distinct neural correlates of obsessive-

29
compulsive and related disorders. Psychiatr Clin North Am. 2006;29:391.
Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y, et al. Reduced serotonin
transporter binding in the insular cortex in patients with obsessive–compulsive disorder:
A DASB PET study. Neuroimage. 2010;49:121-6.
McCarthy G, Wood CC. Scalp distributions of event-related potentials: an ambiguity associated
with analysis of variance models. Electroencephalogr Clin Neurophysiol. 1985;62:203.
Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating
evidence from neuroimaging and neuropsychological studies of obsessive-compulsive
disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev
2008;32:525-49.
Miyata, Matsunaga, Kiriike, Iwasaki, Takei, Yamagami. Event-related potentials in patients
with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 1998;52:513-8.
Miyata, Matsunaga, Kiriike, Iwasaki, Takei, Yamagami. Event-related potentials in patients
with obsessive-;compulsive disorder. Psychiatry Clin Neurosci. 1998;52:513-8.
Morault P, Bourgeois M, Laville J, Bensch C, Paty J. Psychophysiological and Clinical Value
of Event-Related Potentials in Obsessive-Compulsive Disorder. Biol Psychiatry. 1997
1997/7/1;42:46-56.
Muller J, Roberts J. Memory and attention in Obsessive-Compulsive Disorder: a review. J
Anxiety Disord. 2005;19:1-28.
Murphy F, Sahakian B, Rubinsztein J, Michael A, Rogers R, Robbins T, et al. Emotional bias
and inhibitory control processes in mania and depression. Psychol Med. 1999;29:130721.
Nigg JT. On inhibition/disinhibition in developmental psychopathology: Views from cognitive
and personality psychology and a working inhibition taxonomy. Psychol. Bull.
2000;126:220-46.
Norra C, Mrazek M, Tuchtenhagen F, Gobbelé R, Buchner H, Saß H, et al. Enhanced intensity
dependence as a marker of low serotonergic neurotransmission in borderline personality
disorder. J Psychiatr Res. 2003;37:23-33.
Oades RD, Dittmann-Balcar A, Schepker R, Eggers C, Zerbin D. Auditory event-related
potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with
attention-deficit or tourette/tic symptoms. Biol Psychol. 1996;43:163-85.
Oades RD, Zerbin D, Dittmann-Balcar A, Eggers C. Auditory event-related potential (ERP)
and difference-wave topography in schizophrenic patients with/without active
hallucinations and delusions: a comparison with young obsessive-compulsive disorder
(OCD) and healthy subjects. Int J Psychophysiol. 1996;22:185-214.
Obsessive compulsive cognitions working g. Development and initial validation of the
obsessive beliefs questionnaire and the interpretation of intrusions inventory. Behav Res
Ther. 2001;39:987-1006.
Obsessive Compulsive Cognitions Working Group. Psychometric validation of the obsessive
belief questionnaire and interpretation of intrusions inventory--Part 2: Factor analyses
and testing of a brief version. Behav Res Ther. 2005;43:1527-42.
Obsessive Compulsive Cognitions Working Group. Cognitive assessment of obsessivecompulsive disorder. Behav Res Ther. 1997 1997/7;35:667-81.
Ohta H, Yamagata B, Tomioka H, Takahashi T, Yano M, Nakagome K, et al. Hypofrontality in
panic disorder and major depressive disorder assessed by multi-channel near-infrared
spectroscopy. Depress Anxiety. 2008;25:1053-9.
Olley A, Malhi G, Sachdev P. Memory and executive functioning in obsessive-compulsive
disorder: A selective review. J Affect Disord. 2007;104:15-23.
Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG. Cognitive impairment in the euthymic
phase of chronic unipolar depression. J Nerv Mental Dis. 1997;185:748-54.

30
Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A, et al. In vivo PET study
of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive
disorder. NeuroImage. 2008;42:306-14.
Picton TW, Bentin S, Berg P, Donchin E, Hillyard R, Johnson RJ, et al. Guidelines for using
human event-related potentials to study cogntion: recording standards and publication
criteria. Psychophysiology. 2000.
Posner MI, Snyder CR. Facilitation and inhibition in the processing of signals. In: Rabbitt
PMA, Dornic S, editors. Attention and Performance London: Academic Press; 1975. p.
669-81.
Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D. Meta-analytical comparison of
voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety
disorders. Arch Gen Psychiatry. 2010;67:701.
Ratcliff R. Methods for dealing with reaction time outliers. Psychol Bull. 1993;114: 510.
Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The Functional Neuroanatomy of
Anxiety: A Study of Three Disorders Using Positron Emission Tomography and
Symptom Provocation. Biol Psychiatry. 1997;42:446-52.
Roberts LE, Rau H, Lutzenberger W, Birbaumer N. Mapping P300 waves onto inhibition:
Go/No---Go discrimination. Electroencephal Clin Neurophysiol. 1994;92:44-55.
Roche RAP, Garavan H, Foxe JJ, O’Mara SM. Individual differences discriminate eventrelated potentials but not performance during response inhibition. Exp Brain Res.
2005;160:60-70.
Roth RM, Saykin AJ, Flashman LA, Pixley HS, West JD, Mamourian AC. Event-Related
Functional Magnetic Resonance Imaging of Response Inhibition in ObsessiveCompulsive Disorder. Biol Psychiatry. 2007;62:901-9.
Ruchsow M, Reuter K, Hermle L, Ebert D, Kiefer M, Falkenstein M. Executive control in
obsessive-compulsive disorder: event-related potentials in a Go/Nogo task. J Neural
Transm. 2007;114:1595-601.
Salisbury DF, Griggs CB, Shenton ME, McCarley RW. The NoGo P300 ‘anteriorization’effect
and response inhibition. Clin Neurophysiol. 2004;115:1550-8.
Salisbury DF, Griggs CB, Shenton ME, McCarley RW. The NoGo P300anteriorization'effect
and response inhibition. Clin neurophysiol. 2004;115:1550.
Sanz M, Molina V, Martin-Loeches M, Calcedo A, Rubia FJ. Auditory P300 event related
potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder
patients. Psychiatr Res. 2001;101:75-81.
Saxena S, Rauch SL. Functional Neuroimaginc and the anatomy of obsessive-compulsive
disorder. Psychiatr Clin North Am. 2000;23:563-86.
Schall U, Schon A, Zerbin D, Bender S, Eggers C, Oades RD. A left temporal lobe impairment
of auditory information processing in schizophrenia: an event-related potential study.
Neurosci Lett. 1997;229:25-8.
Semlitsch HV, Anderer P, Schuster P, Presslich O. A solution for reliable and valid reduction
of ocular artifacts, applied to the P300 ERP. Psychophysiology. 1986;23:695-703.
Senkowski D, Linden M, Zubrägel D, Bär T, Gallinat J. Evidence for disturbed cortical signal
processing and altered serotonergic neurotransmission in generalized anxiety disorder.
Biol Psychiatry. 2003;53:304-14.
Simpson HB, Rosen W, Huppert JD, Lin SH, Foa EB, Liebowitz MR. Are there reliable
neuropsychological deficits in obsessive–compulsive disorder? J Psychiatr Res.
2006;40:247-57.
Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, et al. Should OCD be
classified as an anxiety disorder in DSM-V? Depress Anxiety. 2010;27:495-506.
Tabachnick BG, Fidell LS, Osterlind SJ. Using Multivariate Statistics. 2001. Allyn and Bacon

31
Boston.
Taylor S. Endophenotypes of obsessive–compulsive disorder: Current status and future
directions. J Obsessive Compuls Relat Disord. 2012;1:258-62.
Thomas SJ, Gonsalvez CJ, Johnstone SJ. Neural time course of threat-related attentional bias
and interference in panic and obsessive-compulsive disorders. Biol Psychol.
2013;94:116-129.
Thomas SJ, Gonsalvez CJ, Johnstone SJ. Sequence effects in the Go/NoGo task: Inhibition and
facilitation. Int J Psychophysiol. 2009;74:209-219.
Towey J, Bruder G, Hollander E, Friedman D, Erhan H, Liebowitz M, et al. Endogenous eventrelated potentials in obsessive-compulsive disorder. Biol Psychiatry. 1990;28:92-8.
Towey J, Bruder G, Tenke C, Leite P, DeCaria C, Friedman D, et al. Event-related potential
and clinical correlates of neurodysfunction in obsessive-compulsive disorder. Psychiatr
Res. 1993;49:167-81.
van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, et al.
Disorder-specific neuroanatomical correlates of attentional bias in obsessivecompulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry.
2005;62:922-33.
Wang J, Miyazato H, Randall M, Hokama H, Hiramatsu K, Ogura C. The N200 abnormalities
of auditory event-related potentials in patients with panic disorder. Prog
Neuropsychopharmacol Biol Psychiatry. 2003;27:1013-21
Warren CM, Tanaka JW, Holroyd CB. What can topology changes in the oddball N2 reveal
about underlying processes? Neuroreport. 2011;22:870-4.
Whiteside SP, Port JD, Abramowitz JS. A meta–analysis of functional neuroimaging in
obsessive–compulsive disorder. Psychiatr Res Neuroimag. 2004;132:69-79.
World Health Organization. Composite International Diagnostic Interview: Administrator's
guide and reference. Geneva, World Health Organization; 1997.
Wise V, McFarlane AC, Clark CR, Battersby M. Event-related potential and autonomic signs
of maladaptive information processing during an auditory oddball task in panic
disorder. Int J Psychophysiol. 2009;74:34-44.

Legend of figures
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Legend of figures
Figure 1. Example of a stimulus train with four Go stimuli. A baseline stimulus (!) is followed by 1-4
go stimuli, and a NoGo stimulus (X-NoGo). These stimuli were followed by either another Go
stimulus (X-Go) or dedicated NoGo stimulus (square), which are not examined here.

Figure 2. Grand mean waveforms to Go versus NoGo stimuli, by group.
Figure 3. Mean N2 amplitude across Go and NoGo stimuli, by Sagittal plane and Group.
Figure 4. Grand mean waveforms to NoGo stimuli as a function of the number of
immediately preceding Go stimuli in trains (GN-GGGGN), by Group. Note: x axis ticks =
100ms; y axis indicates stimulus onset.
Figure 5. Mean ERP amplitudes to NoGo stimuli for significant Group effects and
interactions. Top left: P1 amplitude by lateral plane and Group: Top right; N1 amplitude
by Lateral plane and Group: Middle left: P2 amplitude by Group: Middle right: P2
amplitude by Sagittal plane and Group: Bottom right. N2 amplitude by Sagittal plane and
Group: Bottom right: P3 amplitude by Sagittal plane and group.
Figure 6. Mean ERP latencies (ms) to NoGo stimuli for significant Group effects and
interactions. Left: N1 latency by Group. Right: N2 latency to NoGo stimuli by number of
preceding Go stimuli (GN-GGGGN) and Group.
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Table 1

Table1. Participant demographic characteristics
Variable

HC
(n = 20)

PD
(n = 20)

OCD
(n = 20)

OCD vs.
HC

OCD vs.
PD

PD vs.
HC

Mean age

33 (± 13)

38 (± 12)

39 (± 14)

Ns

Ns

Ns

13

17

11

Ns

Ns

Ns

18

17

16

Ns

Ns

Ns

SSRI

0

6

8

-

-

-

SNRI

0

0

2

-

-

-

RIMA

0

0

1

-

-

-

TCA

0

1

0

-

-

-

Occasional
0
benzodiazepine

1

1

-

-

-

Combined
0
SSRI and
occasional
benzodiazepine

2

0

-

-

-

Gender

Female

Handedness Right handed
Medication

Total on
0
10
12
***
Ns
***
psychotropic
medication
* p < .05, ** p < .01, *** p < .001. SSRI – selective serotonin reuptake inhibitors; SNRI- Serotoninnorepinephrine reuptake inhibitors; RIMA- Reversible Inhibitor of Monoamine-Oxidase-A.

Table 2

Table 2. Scores in psychometric questionnaires, by group.
HC
(n = 20)

PD
(n = 20)

OCD
(n = 20)

OCD
vs. HC

OCD
vs. PD

PD
vs. HC

M (±)

M (±)

M (±)

-

-

-

Obsessions

-

-

14 (6)

-

-

-

Compulsions

-

-

12 (6)

-

-

-

Y-BOCS Total

-

-

26 (12)

-

-

-

Depression subscale

.59 (1)

1.41 (1)

1.61 (1)

**

Ns

*

Phobic anxiety subscale

.3 (1)

1.86 (2)

1.57 (1)

***

Ns

***

1.01 (1)

1.7 (1)

1.87 (1)

*

Ns

Ns

Anxiety subscale

.53 (1)

1.9 (1)

2.1 (1)

***

Ns

***

BSI Global Severity Index

.6 (1)

1.46 (1)

1.6 (1)

**

Ns

**

Padua Inventory

Total Padua score

13 (11)

20 (14)

49 (33)

***

***

Ns

Obsessional Beliefs
Questionnaire (OBQ-44)

Responsibility/ threat

50 (16)

64 (22)

72 (21)

**

Ns

Ns

Perfectionism/ certainty

55 (20)

67 (23)

74 (23)

*

Ns

Ns

Importance/ control of thoughts

28 (10)

39 (19)

49 (13)

***

Ns

Ns

OBQ-44 Total score

133 (43)

170 (56)

195 (53)

***

Ns

Ns

Variable

Yale Brown
Obsessive-Compulsive Scale
(Y-BOCS)

Brief symptom
inventory (BSI)

Obsessive-Compulsive subscale

* p < .05, ** p < .01, *** p < .001. Note: the Y-BOCS, a measure of OCD severity, was only administered to the OCD group.

Table 3

1

Table 3. Mean RT (Ms) and percentage of errors by stimulus type, serial position and group.
GN-GGGN indicates NoGo stimuli preceded by one-four Go stimuli respectively.
Stimulus

Go
NoGo
GN
GGN
GGGN
GGGGN
Baseline
stimulus

Healthy
control
(HC)
RT (SD)
% Errors (SD)
Errors (SD)
Errors (SD)
Errors (SD)
Errors (SD)
Errors (SD)
Errors (SD)

394 (63)
.03 (.1)
.03 (.1)
.09 (.1)
.09 (.09)
.07 (.08)
.05 (.07)
0.2 (.4)

Panic
disorder
(PD)

Obsessivecompulsive
disorder
(OCD)
458 (85)
448 (90)
.03 (.05) .01 (.02)
.03 (.05)
.01 (.02)
.12 (.3)
.01 (.01)
.15 (.29)
.08 (.1)
.11 (.29)
.05 (.09)
.12 (.3)
.03 (.06)
0.25 (.8)
0.3 (.7)

Table 4

Table 4. ANOVA probabilities for significant overall Group effects and interactions and two-group
comparisons.
Analysis

Measure

Contrast

ANOVA
(P-value)
Overall
Group
effect

Simple effects contrasts
(P-value)
OCD vs. PD
OCD
HC
vs.
vs.
HC
PD

Go versus
NoGo

Inhibition
as a
function of
sequence

N2

amplitude

Group x sagittal (linear)

0.045

0.046

0.051

0.959

P1

amplitude

Group by Laterality
(linear)

0.017

0.621

0.021

0.024

N1

amplitude

0.044

0.104

0.023

0.414

N1

latency

Group by Laterality
(linear)
Group main effect

0.002

0.001

0.002

0.436

P2

amplitude

Group main effect

0.000

0.000

0.015

0.019

N2

amplitude

0.008

0.013

0.017

0.871

latency

Group by Sagittal
(linear)
Group by stimulus

0.019

0.025

0.007

0.678

latency

Group main effect

0.017

0.655

0.008

0.041

amplitude

Group by Sagittal
(linear)

0.006

0.004

0.019

0.711

P3

